Chronic Inflammatory Demyelinating Polyneuropathy (CIDP): Current Therapies and Future Approaches

Area of Science:

• Neurology
• Immunology

Background:

• Chronic inflammatory demyelinating polyneuropathy (CIDP) is an immune-mediated disorder causing peripheral nerve damage and disability.
• Established treatments exist, but CIDP's variable course and lack of predictive markers pose challenges.

Purpose of the Study:

• To review current therapeutic strategies for CIDP.
• To provide an outlook on emerging treatments for CIDP.

Main Methods:

• Literature review of established and novel CIDP therapies.
• Analysis of current clinical guidelines and ongoing research.

Main Results:

• First-line CIDP treatments include corticosteroids, immunoglobulin, and plasma exchange.
• Immunosuppressants and rituximab are used in specific cases.
• Novel therapies targeting Fc receptors are under investigation.

Conclusions:

• CIDP management requires tailored approaches due to disease heterogeneity.
• Ongoing research into novel therapeutics offers future treatment possibilities.